Exploring how machine learning is revolutionizing our understanding of TERT expression in cancer cells and its implications for precision oncology.
Discover how CRISPR systems like Cas13 and Cas12a are transforming disease detection with SHERLOCKv2 technology, enabling portable, multiplexed nucleic acid diagnostics.
Exploring how nano-biointerfaces are overcoming biological barriers to revolutionize drug delivery systems
Discover how the RISK system uses machine learning to predict venous thromboembolism in cancer patients with unprecedented accuracy.
Exploring how radiation biomarkers are transforming cancer treatment, space travel safety, and disaster response through cutting-edge molecular diagnostics.
Exploring how bacteriophages are transforming vaccine delivery through thermostable, inexpensive platforms for infectious diseases and cancer.
How Cephalon's acquisition of Arana Therapeutics and their domain antibody technology transformed biologics development
How a correction to a cervical cancer methylation study improves early detection research for high-risk populations in North India.
Discover how Epigenomics AG is revolutionizing cancer detection through epigenetic biomarkers in blood tests, with insights from colorectal cancer screening to poultry heat stress adaptation.
How Vertex Pharmaceuticals' stem cell therapy could revolutionize type 1 diabetes treatment and potentially eliminate insulin injections.